BN Business News
Add your company to Business Communicator →

Business · 07/03/2023Updated: 10/17/2026 · 1 min read

Fosun Pharma USA Inc. Sees FDA Withdraw Approval of Pemoline Tablets

Summary

The FDA has withdrawn approval of Fosun Pharma USA Inc.'s abbreviated new drug application for pemoline tablets in three strengths, following the company's request and waiver of a hearing.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →